Literature DB >> 30870762

The role of navigated transcranial magnetic stimulation for surgery of motor-eloquent brain tumors: a systematic review and meta-analysis.

Giovanni Raffa1, Antonino Scibilia2, Alfredo Conti2, Giuseppe Ricciardo2, Vincenzo Rizzo3, Adolfo Morelli3, Filippo Flavio Angileri2, Salvatore Massimiliano Cardali2, Antonino Germanò2.   

Abstract

Navigated transcranial magnetic stimulation (nTMS) is an emerging tool for surgery of motor-eloquent intrinsic brain tumors, but a critical reappraisal of the literature evidence has never been performed, so far. A systematic review and meta-analysis was performed searching on PubMed/MEDLINE, and the Cochrane Central Register of Controlled Trials for studies that analyzed the impact of nTMS-based motor mapping on surgery of patients affected by motor-eloquent intrinsic brain tumors, in comparison with series of patients operated without using nTMS. The impact of nTMS mapping was assessed analyzing the occurrence of postoperative new permanent motor deficits, the gross total resection rate (GTR), the size of craniotomy and the length of surgery. Only eight studies were considered eligible and were included in the quantitative review and meta-analysis. The pooled analysis showed that nTMS motor mapping significantly reduced the risk of postoperative new permanent motor deficits (OR = 0.54, p = 0.001, data available from eight studies) and increased the GTR rate (OR = 2.32, p < 0.001, data from seven studies). Moreover, data from four studies documented the craniotomy size was reduced in the nTMS group (-6.24 cm2, p < 0.001), whereas a trend towards a reduction, even if non significant, was observed for the length of surgery (-10.30 min, p = 0.38) in three studies. Collectively, currently available literature provides data in favor of the use of nTMS motor mapping: its use seems to be associated with a reduced occurrence of postoperative permanent motor deficits, an increased GTR rate, and a tailored surgical approach compared to standard surgery without using preoperative nTMS mapping. Nonetheless, a growing need of high-level evidence about the use of nTMS motor mapping in brain tumor surgery is perceived. Well-designed randomized controlled studies from multiple Institutions are clearly advocated to continue to shed a light on this emerging topic.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brain tumors; Glioma; Metastasis; Motor cortex; Navigated transcranial magnetic stimulation; Rolandic area

Year:  2019        PMID: 30870762     DOI: 10.1016/j.clineuro.2019.03.003

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  15 in total

Review 1.  Assessing the Capabilities of Transcranial Magnetic Stimulation (TMS) to Aid in the Removal of Brain Tumors Affecting the Motor Cortex: A Systematic Review.

Authors:  Lucas Jose Vaz Schiavao; Iuri Neville Ribeiro; Cintya Yukie Hayashi; Eberval Gadelha Figueiredo; Andre Russowsky Brunoni; Manoel Jacobsen Teixeira; Gabriel Pokorny; Wellingson Silva Paiva
Journal:  Neuropsychiatr Dis Treat       Date:  2022-06-16       Impact factor: 2.989

2.  In Reply: Fluorescence Guidance and Intraoperative Adjuvants to Maximize Extent of Resection.

Authors:  Cordelia Orillac; Daniel A Orringer
Journal:  Neurosurgery       Date:  2022-05-01       Impact factor: 5.315

3.  Pre-surgical fMRI Localization of the Hand Motor Cortex in Brain Tumors: Comparison Between Finger Tapping Task and a New Visual-Triggered Finger Movement Task.

Authors:  Marco Ciavarro; Eleonora Grande; Luigi Pavone; Giuseppina Bevacqua; Michelangelo De Angelis; Paolo di Russo; Roberta Morace; Giorgia Committeri; Giovanni Grillea; Marcello Bartolo; Sergio Paolini; Vincenzo Esposito
Journal:  Front Neurol       Date:  2021-05-14       Impact factor: 4.003

4.  Multimodal integrated approaches in low grade glioma surgery.

Authors:  Tamara Ius; Edoardo Mazzucchi; Barbara Tomasino; Giada Pauletto; Giovanni Sabatino; Giuseppe Maria Della Pepa; Giuseppe La Rocca; Claudio Battistella; Alessandro Olivi; Miran Skrap
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

5.  Evaluation of Changes in Preoperative Cortical Excitability by Navigated Transcranial Magnetic Stimulation in Patients With Brain Tumor.

Authors:  Iuri Santana Neville; Alexandra Gomes Dos Santos; Cesar Cimonari Almeida; Cintya Yukie Hayashi; Davi Jorge Fontoura Solla; Ricardo Galhardoni; Daniel Ciampi de Andrade; Andre Russowsky Brunoni; Manoel Jacobsen Teixeira; Wellingson Silva Paiva
Journal:  Front Neurol       Date:  2021-01-22       Impact factor: 4.003

Review 6.  Preoperative Applications of Navigated Transcranial Magnetic Stimulation.

Authors:  Alexander F Haddad; Jacob S Young; Mitchel S Berger; Phiroz E Tarapore
Journal:  Front Neurol       Date:  2021-01-22       Impact factor: 4.003

7.  Optimizing Adjuvant Stereotactic Radiotherapy of Motor-Eloquent Brain Metastases: Sparing the nTMS-Defined Motor Cortex and the Hippocampus.

Authors:  Yvonne Dzierma; Michaela Schuermann; Patrick Melchior; Frank Nuesken; Joachim Oertel; Christian Rübe; Philipp Hendrix
Journal:  Front Oncol       Date:  2021-02-26       Impact factor: 6.244

8.  Automatic Radiotherapy Planning for Glioblastoma Radiotherapy With Sparing of the Hippocampus and nTMS-Defined Motor Cortex.

Authors:  Michaela Schuermann; Yvonne Dzierma; Frank Nuesken; Joachim Oertel; Christian Rübe; Patrick Melchior
Journal:  Front Neurol       Date:  2022-01-14       Impact factor: 4.003

9.  Preoperative nTMS and Intraoperative Neurophysiology - A Comparative Analysis in Patients With Motor-Eloquent Glioma.

Authors:  Tizian Rosenstock; Mehmet Salih Tuncer; Max Richard Münch; Peter Vajkoczy; Thomas Picht; Katharina Faust
Journal:  Front Oncol       Date:  2021-05-21       Impact factor: 6.244

10.  Mapping and Preserving the Visuospatial Network by repetitive nTMS and DTI Tractography in Patients With Right Parietal Lobe Tumors.

Authors:  Giovanni Raffa; Maria Catena Quattropani; Giuseppina Marzano; Antonello Curcio; Vincenzo Rizzo; Gabriella Sebestyén; Viktória Tamás; András Büki; Antonino Germanò
Journal:  Front Oncol       Date:  2021-06-25       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.